This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Archer Daniels (ADM) Rises More Than 21% YTD: Can It Continue?
by Zacks Equity Research
Archer Daniels (ADM) remains well-poised for long-term growth on the back of healthy demand for its products and other growth efforts, including its Readiness program.
4 Consumer Products Stocks in Focus Amid Industry Challenges
by Vrishali Bagree
The Zacks Consumer Products - Staples industry players are battling cost inflation, supply-chain woes and volatile demand. However, solid online sales and saving efforts keep Newell Brands (NWL), Chewy (CHWY), Albertsons Companies (ACI) and Tupperware Brands (TUP) well positioned.
Chewy (CHWY) to Post Q2 Earnings: What Awaits the Stock?
by Zacks Equity Research
Chewy's (CHWY) second-quarter performance is likely to have gained from growth in active customer base. Also, strong pet health and service offerings are likely to have been upsides.
Hormel Foods (HRL) Queued for Q3 Earnings: Things to Note
by Zacks Equity Research
Hormel Foods' (HRL) third-quarter fiscal 2021 performance is likely to reflect robust demand in retail and deli channel. Recovery in the foodservice channel is also an upside.
Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Consumer Staples
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Is a Surprise Coming for Chewy (CHWY) This Earnings Season?
by Zacks Equity Research
Chewy (CHWY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here's How Conn's (CONN) is Positioned Ahead of Q2 Earnings
by Zacks Equity Research
Conn's (CONN) Q2 results are likely to reflect benefit from strong customer demand and progress on growth initiatives. Inflationary pressures and higher SG&A expenses remained concerns.
What's in the Cards for American Eagle (AEO) in Q2 Earnings?
by Zacks Equity Research
American Eagle's (AEO) Q2 results are likely to reflect gains from growth across brands, online momentum and strong margins. "Real Power. Real Growth." value creation plan bodes well.
Ollie's Bargain (OLLI) Q2 Earnings Miss, Comps Decline Y/Y
by Zacks Equity Research
Ollie's Bargain's (OLLI) second-quarter performance reflects tough year-over-year comparison and supply chain bottlenecks.
The Zacks Analyst Blog Highlights: AutoNation, Arch Resources, Brunswick, Chewy and Conn's
by Zacks Equity Research
The Zacks Analyst Blog Highlights: AutoNation, Arch Resources, Brunswick, Chewy and Conn's
Zacks Market Edge Highlights: Burlington Stores, NVIDIA, Chewy, Zoom Video and Peloton
by Zacks Equity Research
Zacks Market Edge Highlights: Burlington Stores, NVIDIA, Chewy, Zoom Video and Peloton
5 Top Growth Stocks to Buy as Wall Street Extends Record Run
by Tirthankar Chakraborty
As major U.S. benchmarks close further in the record territory, it's prudent to cash in on this bullish trajectory by investing in growth players like AutoNation (AN), Chewy (CHWY) & Conns (CONN).
Bear of the Day: Kimberly Clark (KMB)
by Madeleine Johnson
After the pandemic catapulted sales, qrowth is now slowing much faster after than the maker of Kleenex anticipated.
Chewy (CHWY) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Chewy (CHWY) closed the most recent trading day at $92.21, moving +0.12% from the previous trading session.
Will Chewy (CHWY) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Chewy (CHWY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wondering if You Should Sell Your Hot Stock?
by Tracey Ryniec
Knowing when to sell a stock is one of the hardest skills to learn as a stock investor. Kevin Cook and Tracey Ryniec share their tips.
Snowflake (SNOW) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Snowflake's (SNOW) second-quarter fiscal 2022 results are likely to benefit from strong demand for Data Cloud platform and expanded clientele.
Combat the Choppy Market With These 5 Low-Beta Stocks
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through choppy market conditions. CHWY, REGN, VSTO, RGR & CICHY are the frontrunners.
Salesforce (CRM) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Salesforce's (CRM) second-quarter fiscal 2022 performance is likely to have benefited from robust demand environment, rapid adoption of cloud-based solutions and strategic acquisitions.
SpartanNash's (SPTN) Earnings Beat in Q2, Sales Decline Y/Y
by Zacks Equity Research
SpartanNash (SPTN) posts weak sales in the second quarter of 2021 due to favorable sales in the previous year on higher pandemic-led demand.
Kimberly-Clark (KMB) Hurt by High Costs, Low Tissue Volumes
by Zacks Equity Research
Kimberly-Clark Corporation (KMB) is battling escalated input costs and other manufacturing expenses. Also, consumer tissue volumes declined in the second quarter.
Intuit to Report (INTU) Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Intuit (INTU) Q4 results likely to reflect gains from extension of tax filing deadline from Apr 15 to May 17, solid demand for tax products, high customer retention rates and widening subscriber base.
Chewy (CHWY) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Chewy (CHWY) closed the most recent trading day at $92.59, moving +0.88% from the previous trading session.
What's in the Offing for Palo Alto Networks' (PANW) Q4 Earnings?
by Zacks Equity Research
While Palo Alto's (PANW) Q4 results are likely to reflect gains from heightened demand for cybersecurity solutions amid the remote-working wave, high expenses might have eroded the company's margins.
The Zacks Analyst Blog Highlights: Chewy, Pinterest, Schlumberger, EOG Resources and Moderna
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chewy, Pinterest, Schlumberger, EOG Resources and Moderna